Disruptive Behaviours Clinical Trials
2 recruiting trials for Disruptive Behaviours. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Disruptive Behaviours clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Fundació Sant Joan de Déu (1), IRCCS Eugenio Medea (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Behavioral Parent Training (BPT) (behavioral, 1 trial), followed by Behavioral Parent Training (BPT) + Support of AI app, methyphenidate.
Track Disruptive Behaviours trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Behavioral Parent Training With and Without AI Support for Children With Disruptive Behaviors
The goal of this clinical trial is to learn if adding an artificial intelligence (AI) application called to standard Behavioral Parent Training (BPT) helps families with children...
Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders
The goal of this observational study is to learn if and how pharmacological and psychotherapeutic group treatments can treat clinical symptoms of children and adolescent patients...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Disruptive Behaviours, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Disruptive Behaviours, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Disruptive Behaviours, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.